The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 18 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Neoplasm Grading  [Clear All Filters]
2018
Lili, E., Chatzistamatiou K., Kalpaktsidou-Vakiani A., Moysiadis T., & Agorastos T. (2018).  Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up.. Medicine (Baltimore). 97(4), e9719.
2016
Michalaki, M., Bountouris P., Roupas N. D., Theodoropoulou A., Agalianou N., Alexandrides T., et al. (2016).  Low-risk papillary thyroid carcinoma patients who underwent near-total thyroidectomy without prophylactic central compartment lymph node dissection and were ablated with low-dose 50mCi RAI had excellent 10-year prognosis.. Hormones (Athens). 15(4), 511-517.
2015
Lallas, A., Pyne J., Kyrgidis A., Andreani S., Argenziano G., Cavaller A., et al. (2015).  The clinical and dermoscopic features of invasive cutaneous squamous cell carcinoma depend on the histopathological grade of differentiation.. Br J Dermatol. 172(5), 1308-15.
Agorastos, T., Chatzistamatiou K., Katsamagkas T., Koliopoulos G., Daponte A., Constantinidis T., et al. (2015).  Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology.. PLoS One. 10(3), e0119755.
Giotopoulou, N., Valiakou V., Papanikolaou V., Dubos S., Athanassiou E., Tsezou A., et al. (2015).  Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.. Clin Exp Metastasis. 32(3), 255-65.
2014
Lakis, S., Kotoula V., Eleftheraki A. G., Batistatou A., Bobos M., Koletsa T., et al. (2014).  The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.. Breast. 23(3), 234-43.
Toesca, A., Botteri E., Lazzeroni M., Vila J., Manika A., Ballardini B., et al. (2014).  Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence.. Breast. 23(6), 829-35.
Karavasilis, V., Kosmidis P., Syrigos K. N., Mavropoulou P., Dimopoulos M. A., Kotoula V., et al. (2014).  Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group.. Anticancer Res. 34(10), 5649-55.
Kalogiannidis, I., Petousis S., Bobos M., Margioula-Siarkou C., Topalidou M., Papanikolaou A., et al. (2014).  HER-2/neu is an independent prognostic factor in type I endometrial adenocarcinoma.. Arch Gynecol Obstet. 290(6), 1231-7.
Koumarianou, A., Tzeveleki I., Mekras D., Eleftheraki A. G., Bobos M., Wirtz R., et al. (2014).  Prognostic markers in early-stage colorectal cancer: significance of TYMS mRNA expression.. Anticancer Res. 34(9), 4949-62.
Krikelis, D., Kotoula V., Bobos M., Fountzilas E., Markou K., Karasmanis I., et al. (2014).  Protein and mRNA expression of notch pathway components in operable tumors of patients with laryngeal cancer.. Anticancer Res. 34(11), 6495-503.
L Molife, R., Omlin A., Jones R. J., Karavasilis V., Bloomfield D., Lumsden G., et al. (2014).  Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.. Future Oncol. 10(2), 219-31.
2013
Fountzilas, G., Dafni U., Bobos M., Kotoula V., Batistatou A., Xanthakis I., et al. (2013).  Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy.. BMC Cancer. 13, 163.
Pentheroudakis, G., Spector Y., Krikelis D., Kotoula V., Meiri E., Malamou-Mitsi V., et al. (2013).  Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.. Clin Exp Metastasis. 30(4), 431-9.
Karavasilis, V., Kotoula V., Pentheroudakis G., Televantou D., Lambaki S., Chrisafi S., et al. (2013).  A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.. J Neurol. 260(6), 1469-80.
2012
Zarogoulidis, P., Chatzaki E., Hohenforst-Schmidt W., Goldberg E. P., Galaktidou G., Kontakiotis T., et al. (2012).  Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review.. Cancer Gene Ther. 19(9), 593-600.
Panagopoulou, P., Gogas H., Dessypris N., Maniadakis N., Fountzilas G., & Petridou E. Th (2012).  Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study.. Eur J Epidemiol. 27(11), 857-66.
2011
Basdanis, G., Mekras A., Papadopoulos V. N., Karamanlis E., Paramythiotis D., Mekras D., et al. (2011).  A retrospective analysis of 2000 cases with colorectal carcinoma.. Tech Coloproctol. 15 Suppl 1, S107-10.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.